drugset / Trial / NCT04081337
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a study of tirzepatide in participants with obesity. The main purpose is to learn more about how tirzepatide affects the number of calories participants burn and the amount of food they eat. The study lasted for 28 weeks and will include about 21 visits to the study center.
Timeline
- Start
- 2020-07-09
- Primary completion
- 2022-05-26
- Completion
- 2022-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirzepatide | Peptide | 15 mg | Subcutaneous |